CINECA IRIS Institutional Research Information System

PETRINI, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 37.441
EU - Europa 17.323
AS - Asia 5.696
AF - Africa 536
SA - Sud America 70
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 13
Totale 61.115
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 34.133
IT - Italia 6.208
SE - Svezia 3.517
CA - Canada 3.276
CN - Cina 2.978
BG - Bulgaria 1.612
DE - Germania 1.566
PL - Polonia 995
GB - Regno Unito 923
UA - Ucraina 785
TR - Turchia 756
VN - Vietnam 743
SG - Singapore 737
FI - Finlandia 611
CH - Svizzera 328
CI - Costa d'Avorio 308
HK - Hong Kong 197
IN - India 196
RU - Federazione Russa 194
AT - Austria 163
FR - Francia 142
BE - Belgio 132
SN - Senegal 118
NG - Nigeria 82
BR - Brasile 46
JP - Giappone 30
AU - Australia 29
MX - Messico 27
NL - Olanda 26
CZ - Repubblica Ceca 19
EG - Egitto 18
ES - Italia 15
GR - Grecia 15
IE - Irlanda 15
KR - Corea 15
EU - Europa 12
PT - Portogallo 9
IR - Iran 8
DK - Danimarca 7
HU - Ungheria 7
IL - Israele 7
NZ - Nuova Zelanda 7
IQ - Iraq 6
CL - Cile 5
EE - Estonia 5
RO - Romania 5
RS - Serbia 5
BO - Bolivia 4
EC - Ecuador 4
ID - Indonesia 4
TW - Taiwan 4
CO - Colombia 3
HR - Croazia 3
IS - Islanda 3
LU - Lussemburgo 3
PE - Perù 3
SA - Arabia Saudita 3
ZA - Sudafrica 3
BA - Bosnia-Erzegovina 2
BD - Bangladesh 2
BY - Bielorussia 2
MA - Marocco 2
MU - Mauritius 2
NI - Nicaragua 2
PA - Panama 2
PK - Pakistan 2
TH - Thailandia 2
UY - Uruguay 2
UZ - Uzbekistan 2
A1 - Anonimo 1
AL - Albania 1
ET - Etiopia 1
GE - Georgia 1
GL - Groenlandia 1
GY - Guiana 1
LI - Liechtenstein 1
LT - Lituania 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
PY - Paraguay 1
SC - Seychelles 1
TN - Tunisia 1
VE - Venezuela 1
Totale 61.115
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.250
Ann Arbor 4.242
Fairfield 3.460
Houston 3.292
Chandler 2.903
Serra 2.343
Montreal 2.302
Ashburn 1.844
Sofia 1.608
Milan 1.607
Seattle 1.520
Wilmington 1.248
Beijing 1.200
Cambridge 1.135
Jacksonville 1.112
Ottawa 943
New York 910
Princeton 746
Izmir 734
Lawrence 608
Medford 569
Nanjing 515
Des Moines 391
Dearborn 379
Dong Ket 329
Bern 318
Abidjan 308
Singapore 276
Florence 272
Nanchang 235
Lancaster 223
Jüchen 197
San Diego 194
Hong Kong 182
Rome 166
Redwood City 156
Vienna 153
Boulder 151
London 140
Bremen 134
Kunming 133
Brussels 131
Pisa 130
Dakar 118
Shenyang 115
Hebei 103
Boardman 94
Frankfurt am Main 91
Changsha 89
Washington 86
Ogden 85
Lagos 82
Hefei 80
Jiaxing 78
Los Angeles 76
Westminster 73
Tianjin 63
Norwalk 62
Falls Church 61
Pune 61
Chicago 53
Nürnberg 52
Orange 45
Hangzhou 43
Auburn Hills 40
Guangzhou 34
Düsseldorf 33
Detroit 30
Jinan 29
Phoenix 29
Lanzhou 28
Alessandria 26
Chengdu 22
Changchun 20
San Jose 20
Marseille 19
San Francisco 19
Verona 18
Shanghai 17
Tokyo 17
Zhengzhou 17
Tappahannock 16
Capannori 15
Costa Mesa 15
Hyderabad 15
Council Bluffs 14
Indiana 14
Monza 13
Baotou 12
Sydney 12
Warsaw 12
Wuhan 12
Duncan 11
Edinburgh 11
Leawood 11
Helsinki 10
Kilburn 10
Simi Valley 10
Vicopisano 10
Central District 9
Totale 46.949
Salva come PNG Salva come JPEG
Nome #
EFFICACY AND TOXICITY PROFILES OF LOW-DOSE THALIDOMIDE AS MAINTENANCE THERAPY IN MULTIPLE MYELOMA PATIENTS AFTER DOUBLE OR TRIPLE AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION. 3.356
Atypical APL including multiple translocations and abnormal response to micronuclei induction test 205
CD57 expression on lymphoma microenvironment as a new prognostic marker related to immune dysfunction 203
Acute myeloid leukemia and follicular lymphoma after very low dose radioiodine therapy for thyroid diseases 186
Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen. Leuk Lymphoma 186
1,25(OH)2D3 and TPA in vitro activity on B-CLL. 184
CD45 expression in low-grade B-cell non-Hodgkin's lymphomas 183
Bone tissue engineering: Natural origination or synthetic polymeric scaffolds? 177
Alternating chemotherapy regimen (P-VABEC) for intermediate and high-grade non-Hodgkin's lymphoma of the middle aged and elderly. 176
Bone marrow infiltration in B-cell non-Hodgkin's lymphomas: comparison between flow cytometry and bone marrow biopsy, RECENTI PROGRESSI IN MEDICINA 170
Barium Titanate Nanoparticles: Highly Cytocompatible Dispersions in Glycol-chitosan and Doxorubicin Complexes for Cancer Therapy. 169
Investigation of interactions between poly-L-lysine-coated boron nitride nanotubes and C2C12 cells: up-take, cytocompatibility, and differentiation 168
How Nanotechnology Can Really Improve the Future of Orthopedic Implants and Scaffolds for Bone Defects 168
Is binding of vitamin D binding protein related to cell differentiation? 167
Acute myeloid leukemia and follicular lymphoma after very low dose radioiodine therapy for thyroid diseases 167
Mesenchymal cells inhibit expansion but not cytotoxicity exerted by gamma-delta T cells 162
EVALUATION OF RESISTANCE INDEX OF SEVERAL ANTICANCER AGENTS ON PARENTAL AND RESISTANT P-388 CELL LINES 161
Preparation of stable dispersion of barium titanate nanoparticles: Potential applications in biomedicine 161
Complex translocation t(3;9;22)(q21;q34;q11) at diagnosis is a negative prognostic index in chronic myeloid leukemia. 160
La storia della Facoltà di Medicina e Chirurgia 160
Plasticity of human dental pulp stromal cells with bioengineering platforms: A versatile tool for regenerative medicine. 159
INDOMETHACIN INHIBITION OF BONE-MARROW GRANULOCYTE RELEASE INTO PERIPHERAL-BLOOD 158
Human autologous plasma-derived clot as a biological scaffold for mesenchymal stem cells in treatment of orthopedic healing. 158
IN THE CHRONIC MYELOID LEUKEMIA THE SALIVARY PROTEOMICS RECAPITULATES SOME ASPECTS OF THE LEUKEMIC STEM CELL. LA CELLULA STAMINALE LEUCEMICA E LA PROTEOMICA SALIVARE: IL MODELLO DELLA LEUCEMIA MIELOIDE CRONICA 158
Growing bone tissue-engineered niches with graded osteogenicity: an in vitro method for biomimetic construct assembly 158
Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications 157
Novel biological/biohybrid prostheses for the ossicular chain: fabrication feasibility and preliminary functional characterization 157
MESENCHYMAL CELLS INHIBIT IL2 AND ZOLENDRONATE-INDUCED ?/d T-LYMPHOCYTES 156
Boron nitride nanotubes and primary human osteoblasts: in vitro compatibility and biological interactions under low frequency ultrasound stimulation 156
Pore Size Distribution and Blend Composition Affect In Vitro Prevascularized Bone Matrix Formation on Poly(Vinyl Alcohol)/Gelatin Sponges 155
New approaches for imaging and therapy of solid cancer 154
Response to chemotherapy and tandem autologous transplantation of multiple myeloma patients and GSTP1 and TYMS polymorphisms 153
Identification and purification of mesodermal progenitor cells from human adult bone marrow. 153
5-HT2a inhibitors for progressive multifocal leukoencephalopathy: old drugs for an old disease 152
Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study. 151
Constitutive expression of pluripotency-associated genes in mesodermal progenitor cells (MPCs) 151
CHEMOIMMUNOTHERAPY REGIMEN OF FLUDARABINE, CYCLOPHOSPHAMIDE, AND RITUXIMAB FOLLOWED BY ALEMTUZUM- AB AS INITIAL THERAPY FOR CHRONIC LYMPHOCYTIC LEUKAEMIA: A VALID APPROACH FOR ERADICATION OF MINIMAL RESIDUAL DISEASE 150
B-cell acute lymphoblastic leukemia with t(4;11)(q21;q23) in a young woman: evolution into mixed phenotype acute leukemia with additional chromosomal aberrations in the course of therapy. 150
Treatment of oral mucositis in hematologic patients undergoing autologous or allogeneic transplantation of peripheral blood stem cells: a prospective, randomized study with a mouthwash containing Camelia Sinensis leaf extract 150
Could age modify the effect of genetic variants in IL6 and TNF-a genes in multiple myeloma? 149
Infliximab treatment of grade IV skin acute graft versus host disease 148
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines 148
Development of tissue-engineered substitutes of the ear ossicles: PORP-shaped poly(propylene fumarate)-based scaffolds cultured with human mesenchymal stromal cells. 147
Carboxy-terminal fragment of osteogenic growth peptide regulates myeloid differentiation through RhoA 146
Specific integrin expression is associated with podosome-like structures on mesodermal progenitor cells. 146
Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium. 145
Treatment schedules for 5-HT2A blocking in progressive multifocal leukoencephalopathy using risperidone or ziprasidone 144
β-Cell inflammation in human type 2 diabetes and the role of autophagy 144
Multidrug Resistance and electromagnetic fields 143
Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review). 143
Glycosylation interference on RhoA activation: focus on G-CSF 143
1,25-Dihydroxyvitamin D3-mediated inhibition of human leukemic B cell precursors 142
Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen 142
Kinetics of hematogones in bone marrow samples from patients with non-Hodgkin lymphomas treated with rituximab-containing regimens: a flow cytometric study 142
Oral cyclophosphamide therapy for patients with residual or relapsed indolent-type lymphoma after initial treatment for aggressive lymphomas. A sub-group of patients with apparent transformed indolent lymphoma. 141
EFFICACY OF FLUDARABINE, CYCLOPHOSPHAMIDE, RITUXIMAB (FCR) REGIMEN FOL- LOWED BY ALEMTUZUMAB AS IN VIVO PURGING TOOL FOR PATIENTS WITH ADVANCED CHRONIC LYMPHOCYTIC LEUKEMIA 141
Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies. 141
CD57 and γδ T‐cell receptor expression in nodal metastatic spread of melanoma 141
Processing large-diameter poly(L-lactic acid) microfiber mesh/mesenchymal stromal cell constructs via resin embedding: an efficient histologic method 141
A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patients. 140
Mesangiogenic Progenitor Cells Derived from One Novel CD64brightCD31brightCD14neg Population in Human Adult Bone Marrow 140
Binding of GC (VDBP) to membranes of human B lymphocytes following stripping of extant protein. 139
Reversing of chlorambucil resistance by ethacrynic acid in a B-CLL patient 139
A case of Staphylococcal toxic shock syndrome with expansion of TCR alphaBeta+, CD4/CD8 double negative lymphocytes 139
Leukocyte migration inhibitory activity in the serum of patients affected by Hodgkin's disease and other immunoproliferative diseases 139
Unexpected cardiotoxicity in haematological bortezomib treated patients 138
Comment on "Germinal center helper T cells are dual functional regulatory cells with suppressive activity to conventional CD4+ T cells" 138
Use of Autologous Human mesenchymal Stromal Cell/Fibrin Clot Constructs in Upper Limb Non-Unions: Long-Term Assessment 138
Low-dose ARA-C and 1(OH) D3 administration in acute non lymphoid leukemia: pilot study. 137
CD57+ T lymphocytes and functional immune deficiency 137
HOX and TALE signatures specify human stromal stem cell populations from different sources. 137
Nonpegylated liposomal doxorubicin (MyocetTM) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial 136
Alteraciones funcionales de los granulocitos neutrofilos en un joven neutropenico de raza negra 135
Phenotypic markers in chronic lymphocytic leukemia. 135
Expression of p170 protein in multiple myeloma : a clinical study 135
Expression of MDR1, MRP, TOPOISOMERASE-IIa, TOPOISOMERASE-IIb and GSTp in acute leukemias. 135
Skin and stomach graft versus host disease after syngeneic BMT in CML: A case report., LEUKEMIA RESEARCH,pp 00,tot.pag 00,tot. autori 7,2007 135
Enhancement of neurite outgrowth in neuronal-like cells following boron nitride nanotube-mediated stimulation 135
WT1 GENE EXPRESSION IS SIGNIFICANTLY INHIBITED BY VORINOSTAT AND BORTEZOMIB IN MYELOPROLIFERATIVE/MYELODISPLASTIC DISEASES 134
VDTPACE As Salvage Therapy For Heavily Pretreated MM Patients 134
Association of PIM gene translocation and TELAML1 rearrangement., LEUKEMIA RESEARCH,vol. Leuk Res. 2007 Dec;31(12):1761-2 133
90y Ibritumomab Tiuxetan as Initial Treatment for Follicular Lymphoma (ZEUS Protocol). An Italian Cooperative Study Group 133
CD8 expression in B-cell non-Hodgkin's lymphomas. 133
A PRACTICAL APPROACH TO THERAPEUTIC DRUG MONITORING OF IMATINIB IN PATIENTS AFFECTED BY CHRONIC MYELOID ELEUKEMIA. THE TIKLET PROTOCOL. 133
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia 133
Polymorphisms in regulators of xenobiotic transport and metabolism genes PXR and CAR do not affect multiple myeloma risk: a case-control study in the context of the IMMEnSE consortium. 132
Vitamin D binding protein is produced by human monocytes 131
Bone tissue engineering: natural origination or synthetic polymeric scaffolds? 131
Mesodermal progenitor cells (MPCs) differentiate into mesenchymal stromal cells (MSCs) by activation of Wnt5/calmodulin signalling pathway. 131
Glycosylated or non-glycosylated G-CSF differently influence human granulocyte functions through RhoA 131
Adenosine deaminase activity in human cord blood lymphocyte subpopulations. 130
Thrombocytopenic purpura: an unusual complication of eradication therapy for Helicobacter pylori 130
Immunomodulators and enzymes of purine metabolism in human lymphocytes 129
PS-341 (Bortezomib) inhibits proliferation and induces apoptosis of megakaryoblastic MO7-e cells 129
INTRA-LYMPHOCYTIC ADENOSINE-DEAMINASE AND PURINE NUCLEOSIDE PHOSPHORYLASE-ACTIVITY IN CHRONIC LYMPHOCYTIC-LEUKEMIA - EFFECT OF THYMOSTIMULIN 128
Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium. 128
PS-341 (Bortezomid) inhibits both proliferation of megakaryoblastic cells in vitro and MK colonies production in patients affected by idiopathic myelofibrosis 127
Modern diagnostic and therapeutical approach to cardiac AL amyloidosis and neuroendocrine model of heart failure: lessons from a clinical case. 127
Actin polymerization in neutrophils from donors of peripheral blood stem cells: divergent effects of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor 127
Polycomb genes are associated with response to imatinib in chronic myeloid leukemia 127
Totale 17.960
Salva come PNG Salva come JPEG
Categoria #
all - tutte 145.171
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 145.171
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019984 0 0 0 0 0 0 0 0 0 0 0 984
2019/202011.981 1.307 886 2.340 676 962 1.114 1.208 762 1.003 658 861 204
2020/20214.858 435 198 324 233 509 201 408 449 398 357 423 923
2021/20227.224 157 424 204 571 1.347 928 182 325 338 181 555 2.012
2022/20238.741 1.188 1.176 599 821 940 1.177 81 701 1.384 40 558 76
2023/20249.531 913 749 803 432 973 1.106 210 171 81 3.377 124 592
Totale 61.923